ArticleProceedings of the National Academy of Sciences of the United States of America2019

Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy.

Luca Zammataro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.